Imaging spectrum of cholangiocarcinoma: role in diagnosis, staging, and posttreatment evaluation
Authors:
- 4 February 2016
- journal article
- review article
- Published by Springer Nature in Abdominal Radiology
- Vol. 41 (3) , 553-567
Abstract
Cholangiocarcinoma, a tumor of biliary epithelium, is increasing in incidence. The imaging appearance, behavior, and treatment of cholangiocarcinoma differ according to its location and morphology. Cholangiocarcinoma is usually classified as intrahepatic, perihilar, or distal. The three morphologies are mass-forming, periductal sclerosing, and intraductal growing. As surgical resection is the only cure, prompt diagnosis and accurate staging is crucial. In staging, vascular involvement, longitudinal spread, and lymphadenopathy are important to assess. The role of liver transplantation for unresectable peripheral cholangiocarcinoma will be discussed. Locoregional therapy can extend survival for those with unresectable intrahepatic tumors. The main risk factors predisposing to cholangiocarcinoma are parasitic infections, primary sclerosing cholangitis, choledochal cysts, and viral hepatitis. Several inflammatory conditions can mimic cholangiocarcinoma, including IgG4 disease, sclerosing cholangitis, Mirizzi’s syndrome, and recurrent pyogenic cholangitis. The role of PET in diagnosis and staging will also be discussed. Radiologists play a crucial role in diagnosis, staging, and treatment of this disease.Keywords
This publication has 95 references indexed in Scilit:
- Biliary Tract Cancers in Olmsted County, Minnesota, 1976–2008American Journal of Gastroenterology, 2012
- Clinical diagnosis and staging of cholangiocarcinomaNature Reviews Gastroenterology & Hepatology, 2011
- Risk factors for cholangiocarcinomaHepatology, 2011
- Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinomaJournal of Gastroenterology, 2009
- Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinomaSurgery, 2009
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- Positron emission tomography (PET) for cholangiocarcinomaHPB, 2008
- 18F-fluorodeoxyglucose Positron Emission Tomography Influences Management Decisions in Patients with Biliary CancerJournal of the American College of Surgeons, 2008
- CholangiocarcinomaAnnals of Surgery, 2007
- Biliary tract neoplasms: diagnosis and stagingCancer Imaging, 2007